 dideoxycytidin altern schedul zidovudin children symptomat human immunodefici viru infect object short cours ddc safe antiretrovir activ children symptomat human immunodefici viru infect azidothymidin azt zidovudin goal uninterrupt antiretrovir therapi azt-rel myelosuppress ddc-relat neuropathi method pilot studi dosag level ddc mg/kg hour children month year age diseas control symptomat human immunodefici viru infect thirteen patient prior antiretrovir therapi patient azt dose-limit neutropenia dosag level ddc consecut week rest schedul ddc week week azt therapi hour schedul age-appropri psychometr test start ddc therapi week result week therapi ddc neutropenia anemia patient decreas antigen level cell count mg/kg level rash develop patient mouth sore patient ddc/azt schedul neuropathi conclus antiretrovir activ children safe short interv cours ddc dosag level schedul ddc combin regimen deserv